Monday, 20 October 2014

Aspirin use to prevent cancer draws key researchers to symposium

The Aspirin Reducing Events in the Elderly (ASPREE) clinical trial led by The School of Public Health and Preventive Medicine will be outlined at a symposium in Melbourne this week.

Leading healthcare professionals will also discuss the scientific evidence for and against the use of aspirin for the chemoprevention of cancer. 

Cutting Edge Symposium: Aspirin and Cancer Prevention is focused on the rising importance of disease prevention as a key pillar for controlling the escalating costs of healthcare. Researchers are looking at how aspirin may provide an important addition to other medical approaches to address the challenge. 

The symposium, sponsored by the CSIRO and Monash University, will hear from world-leading researchers working in the field of aspirin and cancer prevention.

Those attending will also learn of the advantages and drawbacks of regular aspirin consumption, and how these impact on aspirin's current and future use in cancer prevention and management.

No comments:

Post a Comment


Related Posts Plugin for WordPress, Blogger...